FinBoss.io
CSEN
  • Home
  • Crypto prices
  • Bitcoin on-chain
  • US macro
  • US stocks
  • Guides
  • How we make money
FinBoss.io
Home
Crypto prices
Bitcoin on-chain
Hashrate
Mining difficulty
Mining pools
Mempool and fees
On-chain activity
MVRV and NUPL
SOPR
Holders
Supply in profit
Rainbow Chart
Fair value
Pi Cycle Top
US macro
FedWatch
Interest rates
Treasury yields
Inflation
Liquidity and Bitcoin
Business cycle
US stocks
Stock screener
Earnings calendar
Insider trading
Market heatmap
Guides
How we make money
CSEN
Home
Stocks
HCA Healthcare Inc
HC

HCA Healthcare Inc

HCAHealth care

Stock · Data from SEC EDGAR 13F · Held by 15 of 87 tracked investors

$469.03
▲ 0.37%
Famous investorshold 15buying 0selling 1
Price (USD)
$469.03
Market cap
$102B
P/E ratio
15.7
Tracked investors holding
15 of 87
Next earnings
27 Oct 2026

HCA Healthcare Inc at a glance

An overview of the financial statements, in plain language. Switch to the advanced view for charts.

FinBoss score
66out of 100
  • Valuation83
  • Growth66
  • Profitability63
  • Quality68
  • Debt25
  • Stability94
In its favour
  • It pays a 0.7% dividend, which takes 10% of earnings.

Earnings results

QuarterReportedEPSAnalyst estimateSurprise
Jun 202624 Jul 20267.597.57+0.3%
Mar 202624 Apr 20267.157.17-0.3%
Dec 202527 Jan 20268.017.36+8.8%
Sep 202524 Oct 20256.965.65+23.2%

EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.

7D
+2.22%
1M
+10.76%
3M
+22.72%
YTD
-0.29%
1Y
+4.92%
3Y
+108.19%
5Y
+87.27%
Forward P/E
14.7
Dividend yield
0.67%
52-week low
$353.99
52-week high
$556.52

Chart HCA

Insider purchases

last 90 days, SEC Form 4
Loading insider trades…

Which investors hold this stock

15
RD
Ray Dalio
Bridgewater Associates
0.33%$79,227,208▲ +16.9%
TG
Tom Gayner
Markel Group
0.25%$32,893,460▲ +2.3%
RP
Richard Pzena
Pzena Investment Management
0.11%$37,662,594▲ +2.5%
MG
Mario Gabelli
GAMCO Investors
0.1%$10,669,340▼ -2.2%
Čn
Česká národní banka
Česká národní banka
0.1%$18,051,102▼ -4.3%
Šn
Švýcarská národní banka
Swiss National Bank
0.09%$172,097,446▼ -5.8%
BN
Bill Nygren
Oakmark (Harris Associates)
0.08%$60,080,879▼ -2.6%
Ns
Norský státní fond
Norges Bank
0.08%$836,457,140New position
JG
Joel Greenblatt
Gotham Asset Management
0.05%$21,627,978▼ -6.5%
GG
Glenn Greenberg
Brave Warrior Advisors
0.04%$1,884,338▲ +262.6%
CA
Cliff Asness
AQR Capital Management
0.03%$87,617,561▼ -31.9%
JS
Jim Simons
Renaissance Technologies
0.01%$7,251,954New position
KG
Ken Griffin
Citadel Advisors
0.01%$71,919,110▼ -28.7%
IE
Israel Englander
Millennium Management
0.01%$24,924,498▲ +373%
KF
Ken Fisher
Fisher Investments
0%$1,172,408▲ +73.3%

Frequently asked questions

How much is HCA Healthcare Inc (HCA) stock?

HCA Healthcare Inc shares trade at $469.03, +0.37% over the last trading day. The price is delayed.

What is the market cap of HCA Healthcare Inc?

The market cap of HCA Healthcare Inc is about $102B and its price-to-earnings ratio (P/E) is 15.7.

Does HCA Healthcare Inc pay a dividend?

The dividend yield of HCA Healthcare Inc is 0.67% a year. The yield can change with the company's decisions.

How has HCA Healthcare Inc stock performed over the last year?

The HCA Healthcare Inc share price changed by +4.92% over 12 months and by +87.27% over 5 years.

Which big investors hold HCA Healthcare Inc?

According to the latest 13F filings, 15 of 87 tracked investors hold HCA Healthcare Inc, for example Ray Dalio, Tom Gayner, Richard Pzena.

When will HCA Healthcare Inc report its next results?

The next earnings report of HCA Healthcare Inc is expected on 27 Oct 2026.

Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.

© 2026 FinBoss.io. All rights reserved.

How we make moneyTerms (Czech)Privacy (Czech)Cookies (Czech)

Disclaimer: the information on this site is for general information only and is not investment or financial advice. Investing involves risk, and cryptocurrencies are especially volatile. Past performance does not guarantee future results. Some links are affiliate links and are marked as ads.

✓
What to watch
  • !Net debt is high: at the current free cash flow it would take 13.5 years to repay.

The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.

Is the stock expensive?

Fairly cheap

For 1 USD of annual earnings you pay 15.7 USD. Based on next year's estimates 14.7 USD.

P/E
15.7×
P/S
1.3×
EV/EBITDA
9.9×

Is the company growing?

Growing slowly
22
23
24
25

Revenue over 3 years grew 7.9% a year. Last year 8.7%.

Does it make money?

Good
  • Cost of sales 59
  • Research 0.0
  • Operations and selling 25.7
  • Taxes and other 6.9
  • Net profit 9.0

Out of 100 USD of revenue, 9.0 USD is left as net profit.

Is it financially healthy?

Watch the debt
Cash
1.1B USD
Debt
51.6B USD
Free CF
3.7B USD

It could repay its net debt from free cash flow in 13.5 years.

Does it pay a dividend?

Pays
Yield
0.67%
Of earnings
10%

Over a year you receive roughly 0.67% of the price per share. The payout is manageable for the company. It has raised the dividend for 5 years in a row.

What do analysts expect?

Buy
Average target
460.59 USD
Vs price
−2%

22 analysts. Their opinion is not a recommendation by FinBoss.io.

Which big investors hold it?

15 of 87

Among the tracked investors, Ray Dalio, Tom Gayner, Richard Pzena and others hold the stock according to 13F filings.

Revenue and net profit (USD B)

Margins (% of revenue)

Free cash flow and capex (USD B)

Cash and debt (USD B)

Earnings per share (EPS, USD)

Latest quarters (USD B)

Dividend per share by year (USD)

* the year has not ended yet. Source: Yahoo Finance.

Ratios

P/E
15.7×
Forward P/E
14.7×
P/B
–
P/S
1.3×
PEG
1.43
EV/EBITDA
9.9×
Gross margin
42.6%
Operating margin
15.2%
Net margin
8.8%
ROE
–
ROA
12.3%
Debt / equity
–
Current ratio
1.0×
Revenue growth
8.7%
Earnings growth
11.6%
Beta
1.11
Dividend
0.67%
Payout ratio
10%